Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Therapeutics for urinary incontinence in development at Dainippon

July 23, 1998

PNU-37883A, a tool for studying the role of K-ATP in renin release

July 16, 1998

NIH finds new selective ligands for studying P2X1 purinoceptors

July 15, 1998

New hormonal agents discovered by Ligand

July 10, 1998

European marketing application submitted for RenaGel

July 10, 1998

Ditropan XL shows favorable efficacy/side effect profile in phase III study

July 8, 1998

Blockade of angiotensin II receptor reduces radiation-induced renal and lung injury

July 7, 1998

P&U characterizes dual inhibitor of both 5alpha-reductase isozymes

July 3, 1998

Positive preliminary results reported for extended-use clinical trial of RenaGel

July 3, 1998

Nippon Shinyaku discovers new treatment for urinary incontinence

June 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...